Latest Breaking News On - Janssen pharmaceutical companies - Page 8 : comparemela.com

DARZALEX® (daratumumab) Subcutaneous Formulation-Based

Meet the moment: Don't set back the clock on patients – POLITICO

A wave of concerning policies around the globe that are currently being implemented or are under discussion will, if the trend continues, have a profoundly negative impact on patients.

Data suggests Esketamine is effective in treating depressive disorders

The Janssen Pharmaceutical Companies of Johnson & Johnson have announced further findings for esketamine nasal spray from the ESCAPE-TRD study

AKEEGA approved for the treatment of prostate cancer with BRCA1/2 mutations

Prostate cancer is one of the most common cancers in men in Ireland

Real-World Analysis Sheds Light on Safety and Efficacy of Teclistamab in R/R Multiple Myeloma

The T-cell redirecting bispecific antibody teclistamab-cqyv demonstrated efficacy and a tolerable safety profile in a real-world population of patients with relapsed/refractory multiple myeloma consistent with that of those enrolled in the phase 2 MajesTEC-1 trial.